RLBD (Real Brands) Common Stock : $2.79 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Real Brands Common Stock?

Real Brands's quarterly common stock stayed the same from Sep. 2023 ($2.79 Mil) to Dec. 2023 ($2.79 Mil) and stayed the same from Dec. 2023 ($2.79 Mil) to Mar. 2024 ($2.79 Mil).

Real Brands's annual common stock increased from Dec. 2021 ($2.77 Mil) to Dec. 2022 ($2.79 Mil) but then stayed the same from Dec. 2022 ($2.79 Mil) to Dec. 2023 ($2.79 Mil).

Real Brands Common Stock Historical Data

The historical data trend for Real Brands's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Real Brands Common Stock Chart

Real Brands Annual Data

Trend

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.15

2.77

2.79

Real Brands Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															2.79	2.79	2.79	2.79	2.79

Real Brands Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Real Brands Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Real Brands Inc (OTCPK:RLBD) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Humbert Street, North Providence, RI, USA, 02991

Website

https://www.realbrandsusa.com

Real Brands Inc is a publicly traded, vertically integrated, early entrant in the hemp-derived cannabinol (CBD) market that specializes in hemp CBD oil/isolate extraction, wholesaling of CBD oils and isolate, manufacturing, production, and sales of hemp-derived CBD consumer, celebrity brands, and white label products.

Executives

James Wells Dobbins	director	5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Thomas Kidrin	officer: President and CEO	11 ROYAL ROAD, BROOKLINE MA 02445
Christopher John Ryan	officer: CFO	11 ROYAL RD, BROOKLINE MA 02445
Leonard Toboroff	director	39 N MOORE ST, STE 6B, NEW YORK NY 10013
Peter N Christos	director
Turning Point Brands, Inc.	10 percent owner	5201 INTERCHANGE WAY, LOUISVILLE KY 40229
Brett S. Spitalny	officer: Chief Operating Officer	2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Jerry Pearring	director, officer: President & CEO	2 SOUTH UNIVERSITY DRIVE, SUITE 220, PLANTATION FL 33324
Ross E Silvey	director	7633 EAST 63RD PLACE, #220, TULSA OK 74133
Terry J Turner	director	7633 EAST 63RD PLACE, #220, TULSA OK 74133
Bernie Gurr	officer: Chief Financial Officer	32751 MATTHEW DRIVE, DANA POINT CA 92629
Bruce Macgregor	officer: Chief Executive Officer, Pres.	5092 RHOADS AVENUE UNIT A, SANTA BARBARA CA 93111
Ken Wiedrich	director	43180 BUSINESS PARK DRIVE SUITE 202, TEMECULA CA 92590